West Pharmaceutical Services, Inc. (WST) Tops Q1 EPS by 16c; Raises FY Guidance
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $346.16 -1.74%
Financial Fact:
Interest expense: 2.2M
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Interest expense: 2.2M
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.81, $0.16 better than the analyst estimate of $0.65. Revenue for the quarter came in at $316.3 million versus the consensus estimate of $308.2 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.50-$2.67, versus prior guidance of $2.37-$2.55 and the consensus of $2.49. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-$1.28 billion, versus prior guidance of $1.215-$1.245 billion and the consensus of $1.23 billion.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.50-$2.67, versus prior guidance of $2.37-$2.55 and the consensus of $2.49. West Pharmaceutical Services, Inc. sees FY2012 revenue of $1.25-$1.28 billion, versus prior guidance of $1.215-$1.245 billion and the consensus of $1.23 billion.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
